Valuation: Asahi Kasei Corporation

Capitalization 1,961B 12.41B 10.62B 9.88B 9.21B 17.21B 1,118B 18.46B 114B 44.73B 535B 46.53B 45.57B P/E ratio 2026 *
14.3x
P/E ratio 2027 * 12.1x
Enterprise value 2,773B 17.54B 15.02B 13.97B 13.02B 24.34B 1,581B 26.1B 161B 63.26B 756B 65.79B 64.44B EV / Sales 2026 *
0.9x
EV / Sales 2027 * 0.85x
Free-Float
95.58%
Yield 2026 *
2.8%
Yield 2027 * 3.07%
More valuation ratios * Estimated data
Dynamic Chart
01-09 Zoll Strengthens Growth Trajectory for Asahi Kasei's Healthcare Sector with U.S. Launch of the Next-Generation Lifevest®? Wcd CI
01-06 Tranche Update on Asahi Kasei Corporation's Equity Buyback Plan announced on November 5, 2025. CI
12-24 Asahi Yukizai Corp to spend 17.5 billion yen to build new production base in Miyazaki, Japan for precision valves for semiconductor manufacturing equipment RE
12-05 Asahi Kasei Strengthens Long-Term Profitability by Phasing Out HMD Production as Part of Structural Reform CI
12-05 Asahi Kasei Corp to discontinue production of hexamethylene diamine RE
12-02 Asahi Kasei accelerates portfolio transformation with divestiture of Daramic lead battery separator business RE
12-02 Kingswood Capital Management, LP acquired Daramic, LLC from Asahi Kasei Corporation. CI
12-01 SENSIL by NILIT and ROICA by Asahi Kasei Collaborate to Reduce Apparel?s Footprint CI
12-01 Asahi Kasei Advance and Teijin Frontier to integrate businesses, effective October 1, 2026 RE
12-01 Teijin Frontier Co., Ltd. concluded a basic agreement to acquire Asahi Kasei Advance Corporation from Asahi Kasei Corporation. CI
11-17 Asahi Kasei: Filed litigation for infringement of patent rights of Ceolus in China RE
11-12 Asahi Kasei Microdevices Showcases AgeTech and PetTech Solutions Combining Privacy and Convenience At CES 2026 CI
11-11 Calliditas Therapeutics Reports Safety Data for Setanaxib in Patients with Alport Syndrome At the American Society of Nephrology Kidney Week CI
More news
1 day-0.79%
1 week+3.96%
Current month+3.96%
1 month+6.57%
3 months+21.86%
6 months+42.06%
Current year+3.96%
More quotes
1 week 1,424
Extreme 1424
1,470
1 month 1,365.5
Extreme 1365.5
1,470
Current year 1,415
Extreme 1415
1,470
1 year 880
Extreme 880
1,470
3 years 880
Extreme 880
1,470
5 years 880
Extreme 880
1,470
10 years 606.1
Extreme 606.1
1,765
More quotes
Manager TitleAgeSince
President 66 01/04/2022
Chief Administrative Officer - -
Corporate Officer/Principal 60 01/04/2011
Director TitleAgeSince
Chairman 70 01/04/2022
Director/Board Member 78 01/06/2018
Director/Board Member 66 01/06/2021
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
-0.79%+3.96%+35.71%+54.69% 12.41B
+1.57%+4.95%-1.56%+53.57% 60.6B
-0.38%+2.01%+7.03%-15.67% 46.24B
+1.11%-0.28%+7.33%+20.28% 16.74B
+0.85%-0.34%+17.07%+38.72% 9.93B
-0.93%+0.92%+1.93% - 8.42B
-0.30%+0.04%-9.82%-25.67% 8.39B
-0.30%+4.19%+20.67%+38.82% 8.19B
+1.30%+2.32%-3.98%-7.66% 5.47B
+0.73%+2.57%+17.03%+52.30% 4.75B
Average +0.29%+1.85%+9.14%+23.26% 18.11B
Weighted average by Cap. +0.53%+2.39%+6.23%+24.51%
See all sector performances

Financials

2026 *2027 *
Net sales 3,075B 19.45B 16.66B 15.49B 14.44B 26.98B 1,753B 28.94B 178B 70.14B 839B 72.95B 71.45B 3,198B 20.23B 17.32B 16.11B 15.02B 28.06B 1,823B 30.1B 186B 72.95B 872B 75.87B 74.31B
Net income 137B 866M 742M 690M 643M 1.2B 78.05B 1.29B 7.94B 3.12B 37.34B 3.25B 3.18B 161B 1.02B 872M 811M 756M 1.41B 91.79B 1.52B 9.34B 3.67B 43.91B 3.82B 3.74B
Net Debt 812B 5.14B 4.4B 4.09B 3.81B 7.13B 463B 7.64B 47.12B 18.52B 221B 19.26B 18.87B 769B 4.86B 4.17B 3.87B 3.61B 6.75B 438B 7.24B 44.63B 17.54B 210B 18.24B 17.87B
More financial data * Estimated data
Logo Asahi Kasei Corporation
Asahi Kasei Corp is a Japan-based company mainly engaged in the materials business, housing business and healthcare business. The Company operates through three business segments. The Materials segment provides styrene monomer, acrylonitrile, polyethylene, automotive-related fibers, electronic materials, mixed signal large scale integrated circuits (LSI), hall elements, deep ultraviolet light-emitting diodes (LEDs), pharmaceutical and food additives and others. The Housing segment provides construction contracting, renovation and other housing-related business, as well as lightweight aerated concrete (ALC), insulation materials and others. The Healthcare segment provides medical drugs, hemodialysis and apheresis related equipment, virus removal filters, cardiopulmonary resuscitation-related products and others. The Company also provides plant engineering, environmental engineering, various research and information provision businesses, and personnel dispatch and introduction services.
Employees
50,352
More about the company
Date Price Change Volume
09/01/26 1,444.00 ¥ -0.79% 4,967,400
08/01/26 1,455.50 ¥ 0.00% 4,656,500
07/01/26 1,455.50 ¥ -0.89% 3,606,800
06/01/26 1,468.50 ¥ +3.42% 4,895,400

Delayed Quote Japan Exchange, January 09, 2026 at 02:30 pm

More quotes
Trader
Investor
Global
Quality
ESG MSCI
AA
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
12
Last Close Price
1,444.00JPY
Average target price
1,503.33JPY
Spread / Average Target
+4.11%
Consensus

Quarterly revenue - Rate of surprise